RoslinCT: RoslinCT and Ayrmid Pharma Ltd. Announce Their Intent to Enter Into a Strategic Partnership to Manufacture FDA Approved Cell Therapy Omisirge (omidubicel-onlv)

Intent that RoslinCT is to perform technology transfer and commercial manufacture of Omisirge® at RoslinCT's cell therapy manufacturing facility in Hopkinton, MA. Omisirge® is a commercialized mis...